• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=7503188; PubMed=9887230).
  

PubMed=1777413; DOI=10.1002/gcc.2870030604
Worsham M.J., Van Dyke D.L., Grenman S.E., Grenman R., Hopkins M.P., Roberts J.A., Gasser K.M., Schwartz D.R., Carey T.E.
Consistent chromosome abnormalities in squamous cell carcinoma of the vulva.
Genes Chromosomes Cancer 3:420-432(1991)

PubMed=7503188; DOI=10.1016/0002-9378(95)90636-3
Hietanen S.H., Kurvinen K., Syrjanen K.J., Grenman S.E., Carey T.E., McClatchey K.D., Syrjanen S.M.
Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Am. J. Obstet. Gynecol. 173:1477-1482(1995)

PubMed=7599042; DOI=10.1038/bjc.1995.289; PMCID=PMC2034151
Hietanen S.H., Grenman S.E., Syrjanen K.J., Lappalainen K., Kauppinen J., Carey T.E., Syrjanen S.M.
Human papillomavirus in vulvar and vaginal carcinoma cell lines.
Br. J. Cancer 72:134-139(1995)

PubMed=9887230; DOI=10.1006/gyno.1998.5194
Rantanen V., Grenman S.E., Kurvinen K., Hietanen S.H., Raitanen M., Syrjanen S.M.
p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Gynecol. Oncol. 71:352-358(1998)

CLPUB00591
Seppanen M.
Cytokines and gynecological cancer. In vitro effects of cytokines on ovarian, endometrial and vulvar carcinoma cells.
Thesis PhD (2000); Tampere University; Tampere; Finland

PubMed=15047230; DOI=10.1016/j.ygyno.2003.12.033
Raitanen M., Worsham M.J., Lakkala T., Carey T.E., Van Dyke D.L., Grenman R., Klemi P., Rantanen V., Isola J.J., Grenman S.E.
Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry.
Gynecol. Oncol. 93:155-163(2004)